Cargando…
Inhibition of adipose triglyceride lipase (ATGL) by the putative tumor suppressor G0S2 or a small molecule inhibitor attenuates the growth of cancer cells
The G0/G1 switch gene 2 (G0S2) is methylated and silenced in a wide range of human cancers. The protein encoded by G0S2 is an endogenous inhibitor of lipid catabolism that directly binds adipose triglyceride lipase (ATGL). ATGL is the rate-limiting step in triglyceride metabolism. Although the G0S2...
Autores principales: | Zagani, Rachid, El-Assaad, Wissal, Gamache, Isabelle, Teodoro, Jose G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695060/ https://www.ncbi.nlm.nih.gov/pubmed/26318046 |
Ejemplares similares
-
Of mice and men: The physiological role of adipose triglyceride lipase (ATGL)()
por: Schreiber, Renate, et al.
Publicado: (2019) -
Interaction between the Triglyceride Lipase ATGL and the Arf1 Activator GBF1
por: Ellong, Emy Njoh, et al.
Publicado: (2011) -
Structure–activity studies in the development of a hydrazone based inhibitor of adipose-triglyceride lipase (ATGL)
por: Mayer, Nicole, et al.
Publicado: (2015) -
Blocking Lipid Uptake Pathways Does not Prevent Toxicity in Adipose Triglyceride Lipase (ATGL) Deficiency
por: Oluwadare, Jide, et al.
Publicado: (2022) -
Adipose triglyceride lipase (ATGL) expression in human skeletal muscle is type I (oxidative) fiber specific
por: Jocken, Johan W. E., et al.
Publicado: (2008)